These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36041632)

  • 41. Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines.
    Ishiguro M; Fukushige T; Iwasaki H; Hamasaki M
    Anticancer Res; 2022 Nov; 42(11):5315-5322. PubMed ID: 36288876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
    Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
    PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of EWSR1 fusions in CCOC by targeted RNA-seq.
    Rivera CM; Faquin WC; Thierauf J; Afrogheh AH; Jaquinet A; Iafrate AJ; Rivera MN; Troulis MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):240-244. PubMed ID: 35165059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
    Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
    BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.
    Ryan JJ; Sprunger ML; Holthaus K; Shorter J; Jackrel ME
    J Biol Chem; 2019 Jul; 294(29):11286-11296. PubMed ID: 31171724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function.
    Fujimura Y; Siddique H; Lee L; Rao VN; Reddy ES
    Oncogene; 2001 Oct; 20(46):6653-9. PubMed ID: 11709699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.
    Liu S; Cheng H; Kwan W; Lubieniecka JM; Nielsen TO
    Mol Cancer Ther; 2008 Jun; 7(6):1751-61. PubMed ID: 18566246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clear cell sarcoma of soft tissue with eccrine differentiation: A case report and review of the literature.
    Sezer E; Çeliker P; Yalçın Ö; Erdem ZB
    J Cutan Pathol; 2021 Aug; 48(8):1034-1037. PubMed ID: 33599302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary Pulmonary Myxoid Sarcoma with
    Nishimura T; Ii T; Inamori O; Konishi E; Yoshida A
    Int J Surg Pathol; 2023 Feb; 31(1):88-91. PubMed ID: 35466725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.
    Ballester LY; Meis JM; Lazar AJ; Prabhu SS; Hoang KB; Leeds NE; Fuller GN
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):347-351. PubMed ID: 32016322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The oncogenic properties of the EWSR1::CREM fusion gene are associated with polyamine metabolism.
    Kaprio H; Siddiqui A; Saustila L; Heuser VD; Gardberg M
    Sci Rep; 2023 Mar; 13(1):4884. PubMed ID: 36966162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex.
    Mo J; Tan K; Dong Y; Lu W; Liu F; Mei Y; Huang H; Zhao K; Lv Z; Ye Y; Tang Y
    Oncogene; 2023 Jan; 42(1):11-25. PubMed ID: 36357572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
    Patel RM; Downs-Kelly E; Weiss SW; Folpe AL; Tubbs RR; Tuthill RJ; Goldblum JR; Skacel M
    Mod Pathol; 2005 Dec; 18(12):1585-90. PubMed ID: 16258500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
    Olsen RJ; Hinrichs SH
    Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts.
    Skálová A; Agaimy A; Vanecek T; Baněčková M; Laco J; Ptáková N; Šteiner P; Majewska H; Biernat W; Corcione L; Eis V; Koshyk O; Vondrák J; Michal M; Leivo I
    Am J Surg Pathol; 2021 Jan; 45(1):1-13. PubMed ID: 33027073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
    Miao X; Chen J; Yang L; Lu H
    J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.
    Schöpf J; Uhrig S; Heilig CE; Lee KS; Walther T; Carazzato A; Dobberkau AM; Weichenhan D; Plass C; Hartmann M; Diwan GD; Carrero ZI; Ball CR; Hohl T; Kindler T; Rudolph-Hähnel P; Helm D; Schneider M; Nilsson A; Øra I; Imle R; Banito A; Russell RB; Jones BC; Lipka DB; Glimm H; Hübschmann D; Hartmann W; Fröhling S; Scholl C
    Nat Commun; 2024 Jan; 15(1):51. PubMed ID: 38168093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
    Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
    Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.